Literature DB >> 25479026

Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.

Olga V Fedorova1, Edward G Lakatta, Alexei Y Bagrov, Olle Melander.   

Abstract

OBJECTIVE: Salt-induced elevation of the endogenous digitalis like sodium pump ligand marinobufagenin (MBG) in the Dahl salt-sensitive rats resulted in elevated blood pressure (BP). Here, we tested, in humans, whether MBG levels are related to ambulatory 24-h BP (ABP), controlled long-term increase of salt-intake induces changes in MBG and any salt-induced change in MBG is related to salt sensitivity.
METHODS: Thirty-nine healthy individuals (53 ± 11 years old; 20 men and 19 women) had a total daily NaCl intake of 50 mmol (low-salt) and 150 mmol (high-salt) for 4 weeks each, in a random order. ABP and MBG in plasma and urine were measured at baseline (unstandardized salt intake) and after high and low-salt intake.
RESULTS: At baseline, plasma MBG (P-MBG) was related to 24-h SBP (r = 0.43, P = 0.007) and DBP (r = 0.32, P = 0.047), whereas 24-h urinary excretion of MBG (UE-MBG) was related to 24-h DBP only (r = 0.42, P = 0.008). Sex-specific analyses revealed that these relationships were significant in men only. Compared with low-salt, high-salt diet increased P-MBG (P = 0.029), mainly driven by results in men. Male P-MBG responders vs. nonresponders (above vs. below median of high-salt induced P-MBG increase) had markedly enhanced SBP (10.4 ± 6.4 vs. 1.0 ± 6.0 mmHg; P = 0.003) and DBP (6.7 ± 5.0 vs. -0.6 ± 3.6 mmHg; P = 0.001) salt sensitivity.
CONCLUSION: In men, MBG increases with 24-h ABP, and similar to Dahl salt-sensitive rats, 4 weeks of high-salt induced MBG response is accompanied by marked salt sensitivity. However, these patterns seem to be sex-specific and are not observed in women.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25479026      PMCID: PMC4543292          DOI: 10.1097/HJH.0000000000000437

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  28 in total

1.  Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.

Authors:  O V Fedorova; A Y Bagrov
Journal:  Am J Hypertens       Date:  1997-08       Impact factor: 2.689

2.  Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.

Authors:  A Y Bagrov; O V Fedorova; R I Dmitrieva; W N Howald; A P Hunter; E A Kuznetsova; V M Shpen
Journal:  Hypertension       Date:  1998-05       Impact factor: 10.190

3.  Pathophysiological consequences of changes in the coupling ratio of Na,K-ATPase for renal sodium reabsorption and its implications for hypertension.

Authors:  D E Orosz; U Hopfer
Journal:  Hypertension       Date:  1996-02       Impact factor: 10.190

4.  The alpha1 Na,K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitiveHSD rat.

Authors:  V L Herrera; H X Xie; L V Lopez; N J Schork; N Ruiz-Opazo
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

5.  Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension.

Authors:  S R Smith; P E Klotman; L P Svetkey
Journal:  J Am Soc Nephrol       Date:  1992-02       Impact factor: 10.121

6.  Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states.

Authors:  H C Gonick; Y Ding; N D Vaziri; A Y Bagrov; O V Fedorova
Journal:  Clin Exp Hypertens       Date:  1998 Jul-Aug       Impact factor: 1.749

7.  Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials.

Authors:  J P Midgley; A G Matthew; C M Greenwood; A G Logan
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

8.  Potassium accelerates urinary sodium excretion during salt loading without stimulating atrial natriuretic polypeptide secretion.

Authors:  M Mano; A Sugawara; Y Nara; K Nakao; R Horie; J Endo; H Imura; Y Yamori
Journal:  Clin Exp Pharmacol Physiol       Date:  1992-12       Impact factor: 2.557

9.  Effect of low and high potassium diets on H(+)-K(+)-ATPase and Na(+)-K(+)-ATPase activities in the rat inner medullary collecting duct cells.

Authors:  C M Helou; M de Araujo; A C Seguro
Journal:  Ren Physiol Biochem       Date:  1994 Jan-Feb

10.  Regulation of the renal Na:K pump: role of progesterone.

Authors:  S K Mujais; N A Nora; Y Chen
Journal:  J Am Soc Nephrol       Date:  1993-02       Impact factor: 10.121

View more
  10 in total

1.  Acute salt loading and cardiotonic steroids in resistant hypertension.

Authors:  Igor V Emelyanov; Alexandra O Konradi; Edward G Lakatta; Olga V Fedorova; Alexei Y Bagrov
Journal:  Curr Top Membr       Date:  2019-02-18       Impact factor: 3.049

Review 2.  The Pressure of Aging.

Authors:  Majd AlGhatrif; Mingyi Wang; Olga V Fedorova; Alexei Y Bagrov; Edward G Lakatta
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

3.  A New Animal Model to Study Endogenous Cardiotonic Steroids and the Progression of Cardiovascular Events in Salt-Sensitive Hypertension.

Authors:  Estela S Estape; Ivette Torres-Negron; Lorena Gonzalez; Manuel Martinez-Maldonado
Journal:  Int Arch Transl Med       Date:  2015-05-30

4.  Large artery stiffness is associated with marinobufagenin in young adults: the African-PREDICT study.

Authors:  Michél Strauss; Wayne Smith; Wen Wei; Alexei Y Bagrov; Olga V Fedorova; Aletta E Schutte
Journal:  J Hypertens       Date:  2018-12       Impact factor: 4.844

Review 5.  The Na+K+-ATPase Inhibitor Marinobufagenin and Early Cardiovascular Risk in Humans: a Review of Recent Evidence.

Authors:  Michél Strauss; Wayne Smith; Olga V Fedorova; Aletta E Schutte
Journal:  Curr Hypertens Rep       Date:  2019-04-12       Impact factor: 5.369

6.  Low to Normal Plasma Levels of Marinobufagenin 24 Hours or More after an Ischemic Stroke: A Pilot Study.

Authors:  Estela S Estapé; Lorena González-Sepúlveda; Wen Wei; Ingrid Rodríguez-Rivera; Ivette Torres-Negrón
Journal:  Int Arch Transl Med       Date:  2018-09-06

7.  The Effects of Short-Term Changes in Sodium Intake on Plasma Marinobufagenin Levels in Patients with Primary Salt-Sensitive and Salt-Insensitive Hypertension.

Authors:  Katarzyna Łabno-Kirszniok; Agata Kujawa-Szewieczek; Andrzej Wiecek; Grzegorz Piecha
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

8.  Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.

Authors:  Yongqing Zhang; Wen Wei; Victoria Shilova; Natalia N Petrashevskaya; Valentina I Zernetkina; Yulia N Grigorova; Courtney A Marshall; Rachel C Fenner; Elin Lehrmann; William H Wood; Kevin G Becker; Edward G Lakatta; Alexei Y Bagrov; Olga V Fedorova
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 6.106

9.  Marinobufagenin is related to elevated central and 24-h systolic blood pressures in young black women: the African-PREDICT Study.

Authors:  Michél Strauss; Wayne Smith; Wen Wei; Olga V Fedorova; Aletta E Schutte
Journal:  Hypertens Res       Date:  2018-01-15       Impact factor: 3.872

Review 10.  Regulation of Cardiac Remodeling by Cardiac Na(+)/K(+)-ATPase Isoforms.

Authors:  Lijun Liu; Jian Wu; David J Kennedy
Journal:  Front Physiol       Date:  2016-09-09       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.